Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell P Levesque

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
EMBO Molecular Medicine|August 20, 2024
Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibitionSarah Proteau, Imène Krossa, Chrystel Husser, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancerDaan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2023
Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 TherapyNina Zila, Ossia M Eichhoff, Irene Steiner, et al.
Molecular Cancer|December 18, 2025
Targeting the tumor cell-intrinsic ITGB2 axis inhibits melanoma progressionErik Rasbach, Laure Migayron, Anne Brandenburg, et al.
Cancer Research|June 7, 2020
The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like PhenotypeNiels Vandamme, Geertrui Denecker, Kenneth Bruneel, et al.
Nature|October 16, 2024
Spatial proteomics identifies JAKi as treatment for a lethal skin diseaseThierry M Nordmann, Holly Anderton, Akito Hasegawa, et al.
Cancer Discovery|January 28, 2025
Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in MelanomaSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Nature Communications|October 17, 2020
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversityFelicity Newell, James S Wilmott, Peter A Johansson, et al.
Cancer Discovery|December 23, 2024
Temporal genomic analysis of homogeneous tumor models reveals key regulators of immune evasion in melanomaSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
EMBO Molecular Medicine|August 20, 2024
Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibitionSarah Proteau, Imène Krossa, Chrystel Husser, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancerDaan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2023
Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 TherapyNina Zila, Ossia M Eichhoff, Irene Steiner, et al.
Molecular Cancer|December 18, 2025
Targeting the tumor cell-intrinsic ITGB2 axis inhibits melanoma progressionErik Rasbach, Laure Migayron, Anne Brandenburg, et al.
Cancer Research|June 7, 2020
The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like PhenotypeNiels Vandamme, Geertrui Denecker, Kenneth Bruneel, et al.
Nature|October 16, 2024
Spatial proteomics identifies JAKi as treatment for a lethal skin diseaseThierry M Nordmann, Holly Anderton, Akito Hasegawa, et al.
Cancer Discovery|January 28, 2025
Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in MelanomaSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Nature Communications|October 17, 2020
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversityFelicity Newell, James S Wilmott, Peter A Johansson, et al.
Cancer Discovery|December 23, 2024
Temporal genomic analysis of homogeneous tumor models reveals key regulators of immune evasion in melanomaSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Pageof 21